Vertigo Drugs Market to grow by USD 551.42 million from 2022-2027, North America to account for 38% of market growth - Technavio
NEW YORK, Sept. 12, 2023 /PRNewswire/ -- The vertigo drugs market size is expected to grow by USD 551.42 million from 2022 to 2027. In addition, the momentum of the market will progress at a CAGR of 5.58% during the forecast period, according to Technavio Research. The market is segmented by Type (Peripheral vertigo and Central vertigo), Distribution Channel (Offline and Online), and Geography (North America, Europe, Asia, and Rest of World (ROW)). North America will contribute 38% to the growth of the global market during the forecast period. The US, Canada, and Mexico are the major contributors to the regional market growth. This is because it addresses the development, manufacturing, and consumption of vertigo drugs, which is driving the development of the regional market. Furthermore, various prominent pharmaceutical companies that develop and manufacture medications for vertigo drugs for vertigo treatment are based in the region. Also, the availability of a wide range of vertigo medications in the region is facilitated by the region's well-established pharmaceutical infrastructure and expertise. Hence, such factors drive the vertigo drugs market in the region during the forecast period. This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. Read PDF Sample Report
Company Profile:
AdvaCare Pharma, Altamira Therapeutics Ltd., Amneal Pharmaceuticals Inc., Endo International Plc, Epic Pharma LLC, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Indicus Pharma, Intas Pharmaceuticals Ltd., Jubilant Pharmova Ltd., Lupin Ltd., Novartis AG, Otonomy Inc., Pfizer Inc., Sensorion, Sound Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Suven Life Sciences Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc.
Altamira Therapeutics Ltd.: The company offers vertigo drugs such as ALTA-5206.
• To gain access to more vendor profiles available with Technavio, buy the report!
By Type Segment - The peripheral vertigo segment will be significant during the forecast period. The vestibular nerve may potentially be a factor in the issue, which links the inner ear to the brain stem and approximately 80% of vertigo is peripheral. Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a PDF Sample Report
"Besides analyzing the current market scenario, our report examines historic data from 2017 to 2021"- Technavio
Vertigo Drugs Market: Driver & Trend:
Drivers
- Rising demand for vertigo drugs in emerging economies
- Increasing healthcare facilities in developing nations
- Increased penetration of online channels
The growing demand for vertigo drugs in developing countries drives the growth of the market. India, China, Brazil, South Africa, Indonesia, Mexico, and others are among the countries driving the demand for these drugs. This demand is characterized by rapid economic growth and rising healthcare costs. Also, factors like the expansion of healthcare infrastructure in emerging economies play an important role in driving the demand for vertigo treatment. Hence, such factors boost the growth of the vertigo drugs market during the forecast period.
Identify key trends, drivers, and challenges in the market. Download to gain access to this information.
Related Reports:
The Antibacterial Drugs Market size is estimated to grow by USD 9,908.11 million at a CAGR of 4.21% between 2022 and 2027. Technavio has segmented the market into Route Of Administration, Drug Class, and Geography. The intravenous segment is estimated to witness significant growth during the forecast period.
The global gastric cancer drugs market size is estimated to grow by USD 12,764.91 million at a CAGR of 14.85% between 2022 and 2027. Technavio has segmented the market into Route Of Administration, Distribution Channel, and Geography. North America is estimated to contribute 40% to the growth of the global market during the forecast period.
What are the key data covered in this vertigo drugs market report?
- CAGR of the market during the forecast period
- Detailed information on factors that will drive the growth of the vertigo drugs market between 2022 and 2027.
- Precise estimation of the vertigo drugs market size and its contribution to the market in focus on the parent market
- Accurate predictions about upcoming trends and changes in consumer behavior
- A thorough analysis of the market's competitive landscape and detailed information about vendors
- Comprehensive analysis of factors that will challenge the growth of vertigo drugs market vendors.
ToC:
Executive Summary
Market Landscape
Market Sizing
Historic Market Sizes
Five Forces Analysis
Market Segmentation by Type
Market Segmentation by Distribution Channel
Market Segmentation by Geography
Customer Landscape
Geographic Landscape
Drivers, Challenges, & Trends
Company Landscape
Company Analysis
Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com
SOURCE Technavio
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article